1,989 material Form 8-K filings that 1,593 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
LTC Properties entered into a new equity distribution agreement allowing it to sell up to $500 million of common stock at its option, through sales agents and forward sale agreements. The filing says the company terminated its prior at-the-market program, under which about $90 million remained unsold, to enter into the new agreement.
Up to $500 million of common stock may be issued and sold from time to time, at the company's option, under the agreement dated August 6, 2026.
The agreement replaces an original program dated November 13, 2024, as amended August 5, 2025, which allowed up to $400 million; about $90 million remained unsold when it was terminated.
Sales agent commissions will not exceed 2.0% of the gross sales price of shares sold through the agents.
Net proceeds may be used to pay down the unsecured revolving line of credit, fund acquisitions and originations, or for working capital and other general corporate purposes.
Procore Technologies completed a private offering of $950 million of 0% convertible senior notes due August 15, 2031, including the full $125 million option for initial purchasers. The conversion price of about $82.89 is a 50% premium over the $55.26 closing price on August 3, 2026, and the notes carry no regular interest, which adds debt but no cash coupon for the company.
Offering of $950 million principal, including the full $125 million option, closed August 6, 2026 under an indenture with U.S. Bank Trust Company as trustee
Initial conversion price of about $82.89 per share, a 50% premium over the $55.26 NYSE closing price on August 3, 2026
Company expected net proceeds of about $804.4 million before the option, or about $926.6 million with it, to fund part of the DroneDeploy cash consideration, a capped call cost of about $51.3 million, and about $175 million of share repurch
Company may not redeem the notes before August 20, 2029, except in a cleanup redemption when less than $100 million remains outstanding
Innodata entered an equity distribution agreement allowing it to sell up to $300 million of common stock through five sales agents, Goldman Sachs and four others. The company has no obligation to sell any shares and may suspend or terminate the offering at any time, and sales would dilute existing shareholders if made.
Agreement dated August 6, 2026 covers shares with an aggregate offering price of up to $300 million.
Sales agents are Goldman Sachs & Co. LLC, Craig-Hallum Capital Group LLC, Wells Fargo Securities, LLC, Maxim Group LLC, and Wedbush Securities Inc.
Sales agents receive a commission of up to 2.0% of gross proceeds from each sale.
Shares would be issued under a Form S-3 shelf registration statement (File No. 333-298075) that became effective upon filing on August 6, 2026.
Solid Biosciences filed a prospectus supplement under its existing shelf registration to offer up to $200.0 million of common stock through a sales agreement with Jefferies LLC. The company said it had already sold about $85.0 million of stock under a prior supplement, which it will no longer use once this one is filed.
Up to $200.0 million of common stock may be sold under the Amended and Restated Sales Agreement dated March 13, 2024 with Jefferies LLC.
Prior prospectus supplement covered up to $85.0 million; about $85.0 million in gross proceeds had been raised under it and the Sales Agreement as of the filing date.
Offering is made under the Form S-3 shelf registration (File No. 333-287325), declared effective May 27, 2025.
Wilmer Cutler Pickering Hale and Dorr LLP issued a legal opinion on the shares (Exhibit 5.1).
Brady Corporation closed its acquisition of Honeywell Technologies' Productivity Solutions and Services (PSS) business on August 3, 2026, in an all-cash transaction valued at $1.4 billion. The company funded it with cash on hand, borrowings under a $1.0 billion credit agreement and $800 million of new senior notes, and it expects the business to add approximately $0.80 of incremental Adjusted Diluted EPS within the first year.
Transaction valued at $1.4 billion, all cash, closed August 3, 2026
Borrowed about $800 million under a $1.0 billion Credit Agreement dated June 12, 2026, and about $800 million under a Note Purchase Agreement
Senior notes: $250 million at 5.43% due 2031, $300 million at 5.65% due 2033, and $250 million at 5.90% due 2036
PSS generated sales of about $1.1 billion in 2025; Brady expects net debt-to-EBITDA of about 2.5x after transaction financing
On August 6, 2026, Clearway Energy entered an equity distribution agreement allowing it to sell up to $100 million of Class C common stock through five agents over time at market prices. The company says proceeds may fund general corporate purposes, including repaying or refinancing debt, working capital, capital expenditures and acquisitions, so shareholders could see dilution if shares are sold.
Program size: up to $100,000,000 aggregate sales price of Class C common stock
Agents named: Wells Fargo Securities, Morgan Stanley, BofA Securities, Citigroup Global Markets and J.P. Morgan Securities
Shares to be issued under a prospectus supplement dated August 6, 2026, to a Form S-3 shelf registration that became effective on August 6, 2026
The filing does not state that any shares have been sold
At its August 4, 2026 annual meeting, Anterix stockholders approved Amendment No. 2 to the 2023 Stock Plan, which adds 1.0 million shares of common stock available for issuance, and elected seven directors. Stockholders also approved the advisory say-on-pay vote and ratified Deloitte & Touche LLP as auditor, so the plan change adds share capacity for future equity awards.
Plan amendment approved with 13,558,280 votes for and 1,099,125 against; it adds 1.0 million shares to the 2023 Stock Plan
Seven directors elected, including Jeffrey A. Altman and Mahvash Yazdi, to serve until the 2027 Annual Meeting
Advisory vote on executive compensation approved with 14,641,617 votes for and 15,894 against; stockholders chose a one-year frequency for future votes
Deloitte & Touche LLP ratified for the fiscal year ending March 31, 2027; quorum was about 90.06% of eligible shares
Organogenesis entered an at-the-market sales agreement with BTIG and Citizens JMP that lets it sell Class A common stock worth up to $75 million through the agents over time. The company is not obligated to sell any shares, so any sales would depend on its instructions and would add to the number of shares outstanding.
Agreement dated August 6, 2026, with BTIG, LLC and Citizens JMP Securities, LLC as sales agents
Aggregate offering price of up to $75,000,000 under a prospectus supplement dated August 6, 2026
Agents receive a commission of up to 3.0% of gross sales price per share sold
Shares are offered under a Form S-3 shelf registration effective August 15, 2024; the company has no obligation to sell
Cedar Realty Trust filed an 8-K stating that its parent, Wheeler Real Estate Investment Trust (WHLR), made available non-public information and supplemental financial information for the three and six months ended June 30, 2026, in a WHLR press release dated August 6, 2026. The filing itself contains no financial figures; the results are furnished as exhibits incorporated by reference from WHLR's separate 8-K.
WHLR press release and supplemental financial information for the three and six months ended June 30, 2026, dated August 6, 2026
Materials furnished as Exhibits 99.1 and 99.2 and available on WHLR's website, www.whlr.us
The filing text does not state revenue, profit, or guidance figures
Filed August 6, 2026 and signed by CEO and President M. Andrew Franklin
KLA Corporation's Board of Directors declared a quarterly cash dividend of $0.23 per share on its common stock, announced August 6, 2026. The dividend is payable September 1, 2026, to shareholders of record as of the close of business on August 17, 2026. The announcement is a routine capital return action and does not include financial results.
Dividend amount: $0.23 per share, declared quarterly
Wingstop increased its board from ten to eleven members and elected Jay Snowden, CEO and President of PENN Entertainment, as an independent Class II director effective August 6, 2026. Snowden joins the Audit and Compensation Committees, which gives the board a new member with senior casino and gaming leadership experience.
Board size increased from ten to eleven members; Snowden fills the new seat effective immediately on August 6, 2026
Snowden receives $100,000 in annual cash compensation for board service
Restricted stock grant valued at approximately $112,500 vests on May 21, 2027
Snowden has been CEO and President of PENN Entertainment since January 2020
Ultra Clean Holdings said CFO Sheri Savage ceased serving as Chief Financial Officer effective August 5, 2026, under a transition agreement, and Michael Keogh took over as CFO on that date. Savage stays on as a non-officer Finance Advisor until May 1, 2027, and the filing states her departure was not due to any disagreement with the company on operations, policies, or financial reporting.
Sheri Savage ceased to be CFO effective August 5, 2026; Michael Keogh succeeds her as CFO on that date
Savage remains employed as a non-officer Finance Advisor until the Separation Date of May 1, 2027
During the garden leave period, her base salary continues, she is eligible for a fiscal 2026 annual bonus, and she receives no salary increase or additional equity awards
Unvested equity awards keep vesting during the period and are forfeited if unvested when her employment ends
Chord Energy said Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary Shannon Kinney will resign effective August 31, 2026, to pursue a General Counsel role at ConocoPhillips. The filing does not name a replacement and says one will be announced at a later time, so shareholders will learn who takes over these responsibilities only after that announcement.
Shannon Kinney notified the company of her resignation on August 2, 2026.
Her resignation takes effect August 31, 2026.
She is leaving to become General Counsel of ConocoPhillips.
Her replacement has not been named and will be announced later.
VICI Properties' operating partnership agreed to sell $900 million of 5.400% notes due 2031 and $850 million of 5.750% notes due 2036, with closing expected August 14, 2026. The company estimates net proceeds of about $1,720.0 million, which it plans to use mainly to repay several 2026 maturities, including $1.25 billion of 4.250% notes due December 2026.
Offering totals $1.75 billion: $900 million of 5.400% notes due October 15, 2031 issued at 99.966% of par and $850 million of 5.750% notes due October 15, 2036 issued at 98.375% of par
Estimated net proceeds of about $1,720.0 million, with closing expected August 14, 2026
Proceeds earmarked to repay $480.5 million of 4.500% notes due 2026, $19.5 million of 4.500% MGP notes due 2026 and $1.25 billion of 4.250% notes due December 2026, with any remainder for general corporate purposes
Zoetis appointed James (Jay) Saccaro, formerly CFO of GE HealthCare, as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. Current CFO Wetteny Joseph will move to a non-executive advisory role and remain with the company until February 28, 2027 or an earlier mutually agreed date. The change puts the finance function and Global Manufacturing and Supply under one executive.
Saccaro's offer letter, dated July 31, 2026, sets a base salary of $1 million and a target annual incentive of 100% of base salary.
Saccaro's annual target long-term incentive is $5 million, and he receives one-time make-whole awards of $6.25 million in restricted stock units and $1.25 million in cash.
Joseph's role as CFO ends after August 16, 2026, or a later date set by the company; his separation benefits follow the Executive Severance Plan.
Saccaro will serve as principal financial officer and principal accounting officer.
Quanta Services issued $2.0 billion of senior unsecured notes on August 6, 2026, in three tranches maturing in 2029, 2033 and 2036, sold under an August 3, 2026 underwriting agreement. The filing adds $2.0 billion of debt to the company's obligations, and the notes are not guaranteed by its subsidiaries, so shareholders should note that their claims rank behind subsidiary creditors.
$500 million of 4.850% Senior Notes due August 9, 2029
$750 million of 5.300% Senior Notes due August 9, 2033
$750 million of 5.550% Senior Notes due August 9, 2036; interest on all three series is payable semi-annually, starting February 9, 2027
Amphenol's board approved a two-for-one stock split paid as a stock dividend, giving holders of record on August 17, 2026 one additional share for each share held. The company said the split lowers its per-share third quarter 2026 Adjusted Diluted EPS guidance to $0.70 to $0.71 from $1.40 to $1.42 before the split, and that the third quarter dividend is $0.125 per share post-split.
Two-for-one stock split paid as a stock dividend; record date August 17, 2026, distribution expected September 2, 2026
Post-split Q3 2026 Adjusted Diluted EPS guidance of $0.70 to $0.71, versus pre-split guidance of $1.40 to $1.42
Q3 2026 dividend of $0.25 per share pre-split ($0.125 post-split), payable October 14, 2026 to holders of record as of September 22, 2026
STAAR Surgical's board appointed Warren Foust, previously its President and COO, as President, CEO and a board member, effective August 4, 2026. Deborah Andrews, who had been Interim Co-CEO since February 2026, stays as Chief Financial Officer and was named Executive Vice President. The filing also details large equity grants to both executives, which will dilute shareholders as they vest.
Warren Foust has been President and COO since March 2025 and joined STAAR in April 2023; his base salary is $730,000 annually.
Foust's CEO grant includes 22,493 time-vesting RSUs, 40,471 time-vesting options and 131,830 performance-vesting options tied to $50, $75 and $100 share price hurdles.
Deborah Andrews will cease as Interim Co-CEO, remain CFO and receive an option grant of 8,952 shares, 29,159 performance options and 4,975 RSUs.
The filing furnishes a press release dated August 4, 2026 as Exhibit 99.1.
Scholar Rock Holding Corporation filed a prospectus supplement for an at-the-market offering that lets it sell up to $200 million of common stock through Jefferies as sales agent, at its discretion. The filing replaces the prior supplement dated November 14, 2025, whose offering has been terminated, and the company says it has raised about $257.7 million in net proceeds under the ATM Program to date. New share sales would add to existing shareholders' ownership and could dilute their stake.
Up to $200,000,000 in additional common stock may be sold through Jefferies, filed August 6, 2026
Replaces the prospectus supplement dated November 14, 2025, which has been terminated
About $257.7 million in net proceeds raised under the ATM Program to date
Shares are registered under a Form S-3ASR shelf filed October 7, 2024
Theriva Biologics said it dosed the first patient in VIRAGE2, a small Phase 2a proof-of-concept study of more frequent repeated dosing of VCN-01 in first-line metastatic pancreatic cancer patients. The study will enroll 6 evaluable patients at a single site in Spain, with enrollment expected to finish in H2 2026 and initial data expected by Q3 2027. The filing reports no revenue, earnings or financial results, and the study is not formally powered to assess clinical efficacy.
First patient dosed in VIRAGE2, announced August 6, 2026
Study planned for 6 evaluable patients at a single site in Spain
Enrollment expected to be completed in H2 2026; initial pharmacodynamic and safety data expected by Q3 2027
Results are intended to inform the VCN-01 dosing regimen for a possible future Phase 3 trial
Genesco said Senior Vice President and Chief Strategy and Digital Officer Parag Desai will move to part-time status on August 7, 2026, and retire effective October 31, 2026. The filing says Desai's responsibilities will transition to other members of the senior leadership team, and the filing contains no financial results or guidance.
Desai stops serving as an executive officer, including for Section 16 purposes, effective August 7, 2026
During the transition period he receives $10,000 per month for up to 32 hours of work per month
He remains eligible for a $338,000 target bonus under the Fiscal 2027 Short-Term Incentive Plan, with individual objectives deemed fully achieved as of August 7, 2026
From November 1, 2026 through January 31, 2027 he will provide consulting services at $2,400 per day
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.